The Boston Globe

Business

Boston.com

Alnylam is cutting 61 jobs

By Chris Reidy

 |  Globe Staff  

  January 20, 2012

Alnylam Pharmaceuticals Inc., a Cambridge biotechnology company, said it plans to cut its workforce by 33 percent, or 61 jobs, as part of a “strategic corporate restructuring” plan. One goal of the plan is to save about $20 million in 2012 cash operating expenses. All the company’s employees work in Cambridge. Alnylam said it is looking to align its resources as it accelerates development of promising drug candidates in its pipeline, including one for hemophilia.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help